Search
for
Sort by
Research 541–570 of 1000+
- Efficacy and safety of baricitinib in patients with alopecia areata: evidence to date
- Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study
- 148 Decreased IL-10 producing regulatory B cells in patients with alopecia areata
- Interleukin 15 Gene Polymorphism in patients with Alopecia Areata
- EE325 Budget Impact of Baricitinib for Patients with Severe Alopecia Areata
- A randomised, open label comparative study of hydroxychloroquine with betamethasone oral mini pulse in the management of patients with alopecia areata
- Infiltration of Mast Cells in Scalp Biopsies of Patients with Alopecia Areata or Androgenic Alopecia Versus Healthy Individuals: A Case-Control Study
- Deficient and/or insufficient serum 25 hydroxy vitamin D in patients with alopecia areata: is it a fact or a fiction?
- Targeting the ovary in female patients with alopecia areata
- Results of Complete Blood Cell Count, Fasting Blood Sugar, Rheumatoid Factor, C - Reactive Protein, Anti Nuclear Antibody and Thyroid Function Tests in Patients with Alopecia Areata
- Infiltration of Mast Cells in Scalp Biopsies of Patients with Alopecia Areata or Androgenic Alopecia Versus Healthy Individuals: A Case-Control Study
- 18883 Androgenetic alopecia pattern hair regrowth in patients with alopecia areata treated with oral JAK inhibitors
- MORPHOLOGICAL CHARACTERISTICS OF EPIDERMIS AND DERMIS IN PATIENTS WITH DIFFUSE ALOPECIA, ANDROGENETIC ALOPECIA AND ALOPECIA AREATA
- Quality of life assessment in patients with alopecia areata and androgenetic alopecia in the People’s Republic of China
- Camouflage technique for alopecia areata: What is a patient to do?
- Increased blood levels of NKG2D+CD4+ T cells in patients with alopecia areata
- Clinical Assessment of Alopecia Areata Severity and Validating the Patient Experience: A Vodcast
- Development of Alopecia Areata Universalis in a Patient Receiving Adalimumab
- New onset of alopecia areata in a patient with SARS‐CoV‐2 infection: Possible pathogenetic correlations?
- Safety and Efficacy of Adalimumab for the Treatment of Severe Alopecia Areata: Case Series of Three Patients
- Alopecia areata secondary to the use of leflunomide in patients with rheumatoid arthritis: a case report and literature review
- Dupilumab for the treatment of alopecia areata in pediatric patients with atopic dermatitis: A scoping review
- COVID-19 vaccination related exacerbations of hair loss in patients with moderate-to-severe alopecia areata on systemic therapy
- P79: Efficacy of baricitinib in adults with alopecia areata: patients’ perspectives on hair regrowth from two phase III randomized controlled trials (BRAVE‐AA1 and BRAVE‐AA2)
- A case of ophiasis type of alopecia areata in a patient with ring chromosome 18 syndrome
- Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)
- Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Etiopathogenesis of alopecia areata: Why do our patients get it?
- Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients